EON Network: August 2025 Newsletter |
The EON Network was established to facilitate communication between exercise oncology and oncology nutrition researchers and clinicians to achieve our joint goal of improving cancer treatment outcomes.
The EON Network monthly newsletter includes upcoming webinars, updates on exercise oncology and oncology nutrition related events, publications that may be of interest, and resources. This information is also available on the EON Network webpage. Past newsletters are archived.
|
|
|
EON Webinar Series: 2025-2026 Presenters
|
The EON Webinar Series returns this fall with an outstanding group of speakers!
As a reminder, recordings of past webinars are available on the EON Network webpage.
|
|
|
October 23, 2025 | 2:00 - 3:00 PM ET
|
|
|
| Exercise Oncology and Oncology Nutrition research funding opportunities with AICR and ACS
Join us as Nigel Brockton, PhD of the American Institute for Cancer Research (AICR) and Joanne Elena, PhD, MPH of the American Cancer Society (ACS) review the research funding opportunities offered by their organizations, as well as their organization's funding priorities. Dr. Brockton will also address the recent AICR announcement regarding harmonization of AICR and World Cancer Research Fund (WCRF) grants fundings program, and the focus on the INSPIRE Research Challenge mechanism during the transition.
|
|
|
December 4, 2025 | 3:00 - 4:00 PM ET
|
|
|
| The CHALLENGE Trial was Positive: What's Next for the Field of Exercise Oncology?
In this presentation, Prof. Courneya will present the results of the groundbreaking CHALLENGE trial demonstrating that structured exercise after adjuvant chemotherapy for colon cancer improves survival. He will then discuss the implications of the first positive phase 3 exercise trial on clinical practice and future research.
|
|
|
February 26, 2026 | 3:00 - 4:00 PM ET
|
|
|
| Improving Oncology Outcomes Through Targeted Nutritional Assessment and Intervention
Cancer and its treatments substantially impact nutritional status and overall patient outcomes. Malnutrition and muscle loss are highly prevalent challenges that compromise treatment tolerance, increase toxicity, and diminish quality of life and survival. This presentation will highlight emerging evidence on the role of targeted nutrition strategies, emphasizing the importance of comprehensive assessment and individualized intervention. Drawing on data from clinical trials and translational research, the session will explore updated insights into energy and protein requirements in oncology, including how factors such as inflammation influence anabolic response. It will also underscore the importance of integrating nutrition into multidisciplinary cancer care to optimize outcomes across the continuum.
|
|
|
|
A new study from the University of Pittsburgh, led by Catherine Phelps and Marlies Meisel, offers new insight into how exercise promotes antitumor immunity by modulating behavior of the microbiome.
Read the full article here.
|
|
|
Phelps CM, Willis NB, Duan T, Lee AH, Zhang Y, Rodriguez J DM, Pandey SP, Laughlin CR, Rosen ABI, McPherson AC, Shapira JH, Randhawa SK, Hedden L, Richie TG, Wiechman HM, Bender MJ, Nemet I, Zöhrer PA, Gottschalk RA, Schmitz KH, Mullett SJ, Gelhaus SL, Davar D, Zarour HM, Hinterleitner R, Mossington T, Badger JH, Rodrigues RR, McCulloch JA, Lee STM, Wagner KH, Winter MG, Winter SE, Das J, Pierre JF, Trinchieri G, Meisel M. Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy. Cell 2025 Jul 4:S0092-8674(25)00684-1. Epub ahead of print. PMID: 40639377
|
|
|
Zwart NRK, Kok DE, Ariyaratne SNH, McKay JA. Folate-associated DNA methylation and chemotherapy-induced toxicities in patients with colorectal cancer. Mol Nutr Food Res 2025 Jul;69(14):e70127. Epub 2025 May 27. PMID: 40420697
Gonzalo-Encabo P, Giobbie-Hurder A, Sears DD, Mayer EL, Partridge AH, Poorvu PD, Waks AG, Tanasijevic AM, Crane TE, Dieli-Conwright CM, Ligibel JA. Combined intermittent fasting and exercise intervention in patients with metastatic, hormone receptor-positive breast cancer (FastER): a pilot study. Breast Cancer Res Treat 2025 Aug 12. Epub ahead of print. PMID: 40794365
Klepin HD, Tooze JA, Rejeski WJ, Mihalko SL, Pardee TS, Ellis LR, Howard DS, Demark-Wahnefried W, Powell BL, Kritchevsky S. Pilot study of an inpatient physical activity intervention for older adults treated intensively for acute myeloid leukemia. Blood Adv 2025 Jul 30:bloodadvances.2025016260. Epub ahead of print. PMID: 40737540
Winters-Stone K, Crisafio M, Chalmers C, Meyers G, Eckstrom E, Campbell KL. A scoping review of exercise oncology trials to inform best practice recommendations for exercise in older adults (65+ years) living with and beyond cancer. J Geriatr Oncol 2025 Aug 9;16(7):102334. Epub ahead of print. PMID: 40784303
Paturi S, Banerjee R. Step count, step aside: Newer physical activity metrics to predict survival in oncology. JCO Clin Cancer Inform 2025 Aug;9:e2500197. Epub 2025 Aug 12. PMID: 40795197
|
|
|
| Call for Papers: Supportive Care in Cancer Special Issue on Cancer-related Fatigue
|
|
|
Drs. Nicolas Hart and Amber Kleckner are leading a special issue of Supportive Care in Cancer on cancer-related fatigue.
This series on cancer-related fatigue focuses on the full spectrum of studies that may improve outcomes for people affected by cancer experiencing cancer-related fatigue. This may include prevention, screening, assessment, diagnosis, interventions, self-management support, and models of care to enhance clinical management, health service performance, and implementation science strategies.
Supportive Care in Cancer is published by Springer in a hybrid format, meaning that you can select "subscription-based," so authors do not have to pay a Article Processing Charges (APC), or "open access," in which the article will be freely available online to everyone.
|
|
|
| Call for Papers: JNCI Cancer Spectrum Special Collection |
|
|
JNCI Cancer Spectrum is calling for papers investigating how exercise and nutrition impact cancer outcomes. Studies that involve clinical trials or prospective data collection over papers that are exploratory and analyze existing data for statistical associations without a well-considered biological mechanism are particularly encouraged. All manuscript types will be considered. Accepted papers will be published normally on advance access and moved into the open issue but also housed in a special collection on the journal website. The deadline for submissions is September 1, 2025.
Please consider submitting your own work to the journal and sharing this announcement with your colleagues.
|
|
|
| Call for Papers: Journal of the Academy of Nutrition and Dietetics Theme Issue |
|
|
The Journal of the Academy of Nutrition and Dietetics (JAND) is pleased to announce a Theme Issue focused on nutrition and cancer. There is great scientific interest in this topic from the discovery of the role of various nutrients, dietary patterns and nutritional status on cancer prevention, control and survivorship to the development and testing of interventions, as well as the implementation and dissemination of nutrition oncology science to stakeholders. This Theme Issue is an opportunity for the research and clinical communities to draw together high-quality original research and reviews that advance our understanding of nutrition and cancer.
Submissions on nutrition and cancer should address populations of interest including (but not limited to):
• The study of populations at risk (low, moderate or high risk) for diet-associated cancers;
• Oncology patients (active treatment) as well as longer-term survivors;
• Patients experiencing or at risk for treatment-related sequalae;
• Caregivers of patients experiencing a cancer diagnosis; and
• Health care providers serving oncology patients.
Submission to this Theme Issue is by pre-approval only. Authors who are interested in submitting an article for this Theme Issue are required to submit an abstract (up to 300 words) to Dr. Wendy Demark-Wahnefried (demark@uab.edu) and Dr. Cynthia Thomson (cthomson@arizona.edu) by August 31, 2025. For all submissions that include research data, this abstract must include: Background, Objective, Design, Participants/Setting, Intervention (if applicable), Main Outcome Measures, Analyses Performed, anticipated or measured Results, and Conclusions, consistent with JAND’s Manuscript Preparation Guidelines. For narrative reviews, this abstract should be in continuous text. Only after abstract review by journal editors, will authors be notified of their invitation to submit a full manuscript to this Theme Issue.
Deadlines:
• Open for abstracts: NOW
• Abstract deadline: August 31, 2025
• Invitations to submit a full article sent out by October 1, 2025
• Full articles due: December 15, 2025
• Theme Issue published October 2026 (subject to change)
|
|
|
NIH/NCI Funding Opportunities |
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
6110 Executive Blvd Suite 750 | Rockville, MD 20852 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
| |
|
|
